October 12 ,2010
Stopping Natalizumab Causes Inflammatory Rebound in MS
http://www.doctorslounge.com/index.php/news/pb/14729
Some multiple sclerosis (MS) patients who discontinue tysabri may experience a rebound of disease activity, according to research published online Oct. 11 in the Archives of Neurology.
Based upon 32 patients who:
-After at least 12 consecutive infusions of Ty
-3-4 month suspension or treatment holiday
-Relapses were experienced by 38% during the interruption or shortly after resumption in
(9 of 24 RR & 3 of 8 SP)
-Relapses occurred more frequently in young patients who has received fewer treatments before suspension
-Restarting Tysabri resulted in resumption of prior disease control in all patients
Stopping Natalizumab Causes Inflammatory Rebound in MS
http://www.doctorslounge.com/index.php/news/pb/14729
Some multiple sclerosis (MS) patients who discontinue tysabri may experience a rebound of disease activity, according to research published online Oct. 11 in the Archives of Neurology.
Based upon 32 patients who:
-After at least 12 consecutive infusions of Ty
-3-4 month suspension or treatment holiday
-Relapses were experienced by 38% during the interruption or shortly after resumption in
(9 of 24 RR & 3 of 8 SP)
-Relapses occurred more frequently in young patients who has received fewer treatments before suspension
-Restarting Tysabri resulted in resumption of prior disease control in all patients
Comment